Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -29.15% is 183% below its 5-year average of -10.29%, around the middle of its 5-year range (-115.48%–7.96%).
12.91% below its 12-month average of -25.82%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1.61%.
NET PROFIT MARGIN
-29.15%
NET PROFIT MARGIN AVG TTM
-25.82%
NET PROFIT MARGIN AVG 3Y
-7.85%
NET PROFIT MARGIN AVG 5Y
-10.29%
NET PROFIT MARGIN AVG 10Y
-12.45%
NET PROFIT MARGIN AVG 15Y
-23.67%
NET PROFIT MARGIN AVG 20Y
-106.81%
CURRENT VS TTM AVG
-12.91%
CURRENT VS 3Y AVG
-271.56%
CURRENT VS 5Y AVG
-183.29%
CURRENT VS 10Y AVG
-134.11%
CURRENT VS 15Y AVG
-23.15%
CURRENT VS 20Y AVG
+72.71%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-11111.54%
vs the sector median at left
Sanara MedTech Inc.
Market Cap
$321.76M
Net Profit Margin
-29.15%
TTM Avg
-25.82%
3Y Avg
-7.85%
5Y Avg
-10.29%
Market Cap
$320.10M
Net Profit Margin
-56.96%
TTM Avg
-82.06%
3Y Avg
-78.03%
5Y Avg
-79.87%
Market Cap
$325.26M
Net Profit Margin
-214.74%
TTM Avg
-178.01%
3Y Avg
-157.31%
5Y Avg
-157.31%
Market Cap
$327.67M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$315.02M
Net Profit Margin
69.34%
TTM Avg
-109.76%
3Y Avg
-150.31%
5Y Avg
-135.75%
Market Cap
$329.89M
Net Profit Margin
-81.76%
TTM Avg
-64.66%
3Y Avg
-75.38%
5Y Avg
-73.80%
Market Cap
$310.69M
Net Profit Margin
-289.44%
TTM Avg
-294.02%
3Y Avg
-409.64%
5Y Avg
-336.94%
Market Cap
$309.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6520.67%
5Y Avg
-12425.66%
Market Cap
$346.14M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sanara MedTech Inc. (SMTI) | $321.76M | -29.15% | -25.82% | -7.85% | -10.29% |
| Avita Medical Inc. (RCEL)vs › | $320.10M | -56.96% | -82.06% | -78.03% | -79.87% |
| CapsoVision, Inc. (CV)vs › | $325.26M | -214.74% | -178.01% | -157.31% | -157.31% |
| Cabaletta Bio, Inc. (CABA)vs › | $327.67M | 0.00% | 0.00% | 0.00% | 0.00% |
| Agenus Inc. (AGEN)vs › | $315.02M | 69.34% | -109.76% | -150.31% | -135.75% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $329.89M | -81.76% | -64.66% | -75.38% | -73.80% |
| C4 Therapeutics, Inc. (CCCC)vs › | $310.69M | -289.44% | -294.02% | -409.64% | -336.94% |
| Benitec Biopharma Inc. (BNTC)vs › | $309.88M | 0.00% | 0.00% | -6520.67% | -12425.66% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $346.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| Turn Therapeutics Inc. (TTRX)vs › | $346.43M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
9.4%
Net Profit Margin
-29.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1.61% |
| 2026-03-31 | 1.65% |
| 2025-12-31 | -5.84% |
| 2025-09-30 | -115.48% |
| 2025-06-30 | -7.80% |
| 2025-03-31 | -15.05% |
| 2024-12-31 | -5.85% |
| 2024-09-30 | -13.19% |
| 2024-06-30 | -17.38% |
| 2024-03-31 | -9.52% |
| 2023-12-31 | -1.34% |
| 2023-09-30 | -6.62% |
| 2023-06-30 | -11.60% |
| 2023-03-31 | -7.59% |
| 2022-12-31 | -26.82% |
| 2022-09-30 | -11.27% |
| 2022-06-30 | 7.96% |
| 2022-03-31 | -40.06% |
| 2021-12-31 | -50.45% |
| 2021-09-30 | -34.69% |
| 2021-06-30 | -18.66% |
| 2021-03-31 | -23.59% |
| 2020-12-31 | -5.15% |
| 2020-09-30 | -26.64% |
| 2020-06-30 | -37.94% |
| 2020-03-31 | -52.12% |
| 2019-12-31 | -43.63% |
| 2019-09-30 | -28.77% |
| 2019-06-30 | -11.65% |
| 2019-03-31 | -6.54% |
| 2018-12-31 | -1024.31% |
| 2018-09-30 | -9.64% |
| 2018-06-30 | 1.38% |
| 2018-03-31 | 0.32% |
| 2017-12-31 | 14.60% |
| 2017-09-30 | -3.14% |
| 2017-06-30 | 5.44% |
| 2017-03-31 | 3.31% |
| 2016-12-31 | 13.46% |
| 2016-09-30 | 12.88% |
| 2016-06-30 | -73.33% |
| 2016-03-31 | 8.24% |
| 2015-12-31 | -63.05% |
| 2015-09-30 | -19.73% |
| 2015-06-30 | -78.15% |
| 2015-03-31 | -13.16% |
| 2014-12-31 | -39.25% |
| 2014-09-30 | -98.81% |
| 2014-06-30 | -142.54% |
| 2014-03-31 | -80.02% |
| 2013-12-31 | -320.78% |
| 2013-09-30 | -356.95% |
| 2013-06-30 | -7.78% |
| 2013-03-31 | -251.46% |
| 2012-12-31 | -160.53% |
| 2012-09-30 | -388.03% |
| 2012-06-30 | -10.99% |
| 2012-03-31 | 276.09% |
| 2011-12-31 | -627.99% |
| 2011-09-30 | -796.48% |
| 2011-06-30 | -1403.61% |
| 2011-03-31 | -293.34% |
| 2010-12-31 | -249.45% |
| 2010-09-30 | -1509.40% |
| 2010-06-30 | -576.64% |
| 2010-03-31 | -1866.11% |
| 2009-12-31 | -2112.39% |
| 2009-09-30 | -251.49% |
| 2009-06-30 | -439.35% |
| 2009-03-31 | -953.17% |
| 2008-12-31 | -1131.16% |
| 2008-09-30 | -443.01% |
| 2008-06-30 | -310.80% |
| 2008-03-31 | -558.29% |
| 2007-12-31 | -310.13% |
| 2007-09-30 | -73.00% |
| 2007-06-30 | -5.38% |
| 2007-03-31 | -206.40% |
| 2006-12-31 | -363.56% |
| 2006-09-30 | -355.64% |
| 2006-06-30 | -324.16% |
| 2006-03-31 | -278.81% |
| 2005-12-31 | -210.11% |
| 2005-09-30 | -208.27% |
| 2005-06-30 | -842.11% |
| 2005-03-31 | -314.61% |
| 2004-12-31 | -1475.96% |
| 2004-09-30 | -18277.65% |
| 2004-06-30 | -412.49% |
| 2004-03-31 | -803.84% |
| 2002-03-31 | 0.00% |
| 2001-12-31 | 50.23% |
| 2001-09-30 | -212.71% |
| 2001-06-30 | -31.63% |
| 2001-03-31 | -4.29% |
| 2000-12-31 | -77.80% |
